OR WAIT null SECS
August 31, 2022
Lonza has introduced X-ray powder diffraction capability at its Monteggio, Switzerland site.
August 30, 2022
Emerson’s new gas analysis solutions center, located in Cumbernauld, Scotland, intends to help plants meet sustainability goals.
Novavax’s COVID-19 vaccine, Nuvaxovid, can now be given to adolescents aged 12 to 17 in the UK.
Canvax’s new inorganic pyrophosphate is designed for in-vitro transcription reactions.
August 29, 2022
The European Union publishes long-awaited changes to Annex 1.
August 26, 2022
Watson-Marlow and Franz Ziel GmbH have launched a new integrated solution to fast-track cell, gene, and biological therapies.
ChargePoint Technology has acquired single-use container company PuroVaso.
August 23, 2022
NICE has recommended the use of Tavneos (avacopan) in combination with rituximab or cyclophosphamide regimen.
Kapruvia (difelikefalin) has been granted approval by Swissmedic as a treatment for moderate-to-severe pruritis associated with CKD.
The European Commission (EC) has approved Celltrion Healthcare's Vegzelma (CT-P16), a biosimilar to bevacizumab referencing Avastin.